Turlande Emília, Paz Lucas Nogueira, Dias Carla Silva, Neto Antenor Leal, Reis Joice Neves, Marques Lucas Miranda, Fernandes Lia, Pinna Melissa Hanzen
Postgraduate Program in Microbiology, Federal University of Bahia, Salvador, Bahia 40170-110, Brazil.
Bacterial Disease Laboratory, Federal University of Bahia, Salvador, Bahia 40170-110, Brazil.
FEMS Microbiol Lett. 2025 Jan 10;372. doi: 10.1093/femsle/fnaf058.
Escherichia coli is a significant pathogen associated with foodborne outbreaks. This study investigated the presence of diarrheagenic, antimicrobial-resistant, and extended-spectrum beta-lactamase (ESBL)-producing E. coli in free-range poultry products in a tropical region. MALDI-TOF/VITEK® 2 system and PCR (Polymerase Chain Reaction) assays were used to detect E. coli, phenotypical antimicrobial resistance profile, virulence, and β-lactam genes. Escherichia coli was identified in 92.3% of poultry meat samples (24/26) and 15.8% of egg samples (6/38 pools). Of these isolates, 60% (18/30) were characterized as diarrheagenic E. coli. The findings revealed a high prevalence of diarrheagenic E. coli strains, including hybrid pathotypes (38.9%, 7/18). Of the 30 (46.7%) E. coli strains, 14 strains showed phenotypic antimicrobial resistance, with 35.7% (5/14) classified as multidrug-resistant (MDR). In addition, 26.7% (8/30) showed phenotypic ESBL production, and 46.7% (14/30) amplified β-lactam resistance genes. Our results highlight the potential contribution to foodborne diseases and emergence of antimicrobial resistance through the dissemination of diarrheagenic, MDR, and ESBL-producing E. coli. This underscores the urgent need to adopt a One Health approach that integrates human, animal, and environmental health.
大肠杆菌是与食源性疾病暴发相关的重要病原体。本研究调查了热带地区散养家禽产品中致泻性、耐抗菌药物和产超广谱β-内酰胺酶(ESBL)的大肠杆菌的存在情况。使用基质辅助激光解吸电离飞行时间质谱/ VITEK® 2系统和聚合酶链反应(PCR)检测大肠杆菌、表型抗菌药物耐药谱、毒力和β-内酰胺基因。在92.3%的禽肉样本(24/26)和15.8%的鸡蛋样本(6/38组)中鉴定出大肠杆菌。在这些分离株中,60%(18/30)被鉴定为致泻性大肠杆菌。研究结果显示致泻性大肠杆菌菌株的患病率很高,包括混合致病型(38.9%,7/18)。在30株(46.7%)大肠杆菌菌株中,14株表现出表型抗菌药物耐药性,其中35.7%(5/14)被归类为多重耐药(MDR)。此外,26.7%(8/30)表现出表型ESBL产生,46.7%(14/30)扩增出β-内酰胺耐药基因。我们的结果强调了通过传播致泻性, MDR和产ESBL的大肠杆菌对食源性疾病和抗菌药物耐药性出现的潜在影响。这突出了采取整合人类、动物和环境卫生的“同一健康”方法的迫切需要。